<DOC>
<DOCNO>EP-0658346</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Use of hydrolytic enzymes for prophylaxis of abortion at pregnant women with idiopathic abortus habitualis in the anamnesis
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3848	A61K3854	A61K3843	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K38	A61K38	A61K38	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
MUCOS PHARMA GMBH 
&
 CO
</APPLICANT-NAME>
<APPLICANT-NAME>
MUCOS PHARMA GMBH 
&
 CO.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
DITTMAR FRIEDRICH-WILHELM PROF
</INVENTOR-NAME>
<INVENTOR-NAME>
KUNZE RUDOLF DR
</INVENTOR-NAME>
<INVENTOR-NAME>
RANSBERGER KARL
</INVENTOR-NAME>
<INVENTOR-NAME>
STAUDER GERHARD DR
</INVENTOR-NAME>
<INVENTOR-NAME>
DITTMAR, FRIEDRICH-WILHELM, PROF. DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
KUNZE, RUDOLF, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
RANSBERGER, KARL
</INVENTOR-NAME>
<INVENTOR-NAME>
STAUDER, GERHARD, DR.
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Use of at least one hydrolytic enzyme for producing a drug for the
prophylaxis of abortion in pregnant women with habitual idiopathic abortion in their

anamneses.
Use according to claim 1, 
characterized in
 that a vegetable protease is
used as said hydrolytic enzyme.
Use according to claim 2, 
characterized in
 that bromelain and/or papain
are used.
Use according to claim 1, 
characterized in
 that an animal protease is used
as said hydrolytic enzyme.
Use according to claim 4, 
characterized in
 that trypsin and/or chymotrypsin
are used.
Use according to any one of claims 1 to 5, 
characterized in
 that rutin is
additionally used.
Use according to any one of claims 1 to 6, 
characterized in
 that at least
one gestagen and/or at least one estrogen are additionally used.
Use according to claim 7, 
characterized in
 that hydroxyprogesterone
caproate is used as gestagen, and estradiol valerate as estrogen.
</CLAIMS>
</TEXT>
</DOC>
